Bristol-Myers Squibb Co’s recently made public that its EVP, Corporate Affairs Short Bartie Wendy unloaded Company’s shares for reported $16719.0 on Aug 02 ’25. In the deal valued at $44.23 per share,378 shares were sold. As a result of this transaction, Short Bartie Wendy now holds 5,066 shares worth roughly $0.24 million.
Then, Hickey Benjamin sold 97 shares, generating $3,702 in total proceeds. Upon selling the shares at $38.01, the President, RayzeBio Org. now owns 0 shares.
Before that, Hirawat Samit bought 4,250 shares. Bristol-Myers Squibb Co shares valued at $202,215 were divested by the EVP,Chief Med.Offr.,Drug Dev. at a price of $47.58 per share. As a result of the transaction, Hirawat Samit now holds 83,513 shares, worth roughly $4.02 million.
Daiwa Securities downgraded its Bristol-Myers Squibb Co [BMY] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. Cantor Fitzgerald began covering BMY with “Neutral” recommendation on April 22, 2025. Jefferies revised its rating on December 16, 2024. It rated BMY as “a Buy” which previously was an “a Hold”.
Price Performance Review of BMY
On Monday, Bristol-Myers Squibb Co [NYSE:BMY] saw its stock fall -0.52% to $48.19. Over the last five days, the stock has gained 4.92%. Bristol-Myers Squibb Co shares have fallen nearly -0.45% since the year began. Nevertheless, the stocks have fallen -14.80% over the past one year. While a 52-week high of $63.33 was reached on 03/11/25, a 52-week low of $42.96 was recorded on 07/31/25.
Levels Of Support And Resistance For BMY Stock
The 24-hour chart illustrates a support level at 47.94, which if violated will result in even more drops to 47.70. On the upside, there is a resistance level at 48.57. A further resistance level may holdings at 48.96.
How much short interest is there in Bristol-Myers Squibb Co?
A steep rise in short interest was recorded in Bristol-Myers Squibb Co stocks on 2025-07-31, dropping by -8.53 million shares to a total of 30.92 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 39.45 million shares. There was a decline of -27.58%, which implies that there is a negative sentiment for the stock.
